Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression.
Cytomegalovirus infection in the renal allograft recipient has been associated with the initiation of acute rejection. The mechanism of this induction is unknown. It may be related to renal tubular epithelial and endothelial expression of HLA class II antigens or a CMV immediate-early antigen that exhibits immunologic crossreactivity with HLA DR. In this study the ability of CMV to both infect and subsequently induce class II antigen expression on cultured human umbilical-vein endothelial cells (HUVEs), in the absence of cytokines, particularly gamma interferon, was tested. Individual HUVE cell lines were first proven to express HLA class II antigens in the presence of 10, 100, and 200 units of recombinant IFN-gamma as early as 24 hr postincubation by an immunohistochemical technique and by flow cytometry. These cell lines were successfully infected with CMV strains AD169 and CMV3 as determined by the presence of early and late viral antigens and CMV DNA. The degree of infection was dose and incubation-time dependent. Infection of HUVEs with these CMV strains and a nonattenuated clinical isolate failed to induce HLA DR, DP, or DQw1 expression in the absence of IFN-gamma. These findings support the hypothesis that endothelial cells in vivo may serve as reservoirs of CMV infection. They do not support the hypothesis that CMV produces an immediate-early antigen that has immunologic cross-reactivity with HLA DR. Furthermore, there is no support for the hypothesis that CMV independently induces HLA class II antigens in the absence of IFN-gamma.
Sedmak
D D
DD
Department of Pathology, Ohio State University College of Medicine, Columbus 43210.
Roberts
W H
WH
Stephens
R E
RE
Buesching
W J
WJ
Morgan
L A
LA
Davis
D H
DH
Waldman
W J
WJ
D002478:Cells, Cultured; D003586:Cytomegalovirus Infections / Q000276:immunology*; D004730:Endothelium, Vascular / Q000382:microbiology*; D006681:HLA-D Antigens / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology; D011994:Recombinant Proteins
D006681:HLA-D Antigens; D011994:Recombinant Proteins; D007371:Interferon-gamma